Anthonia Okolie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anthonia Okolie has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Fatima Muili
4 shared publications- Sunny E. Ohia
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA
3 shared publications Ya Fatou Njie-Mbye
Ophthalmic Pharmacology Research Laboratory, Department of Pharmaceutical Sciences, Joan M. Lafleur College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, United States
3 shared publications- Catherine A. Opere
Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, Omaha, NE, United States
2 shared publications Sunny E. Ohia
2 shared publicationsCatherine A. Opere
1 shared publication
Latest Publications
- Open Access
- 7 March 2026
- Published by Elsevier in SSRN Electronic Journal
HYDROGEN SULFIDE-RELEASING COMPOUNDS ATTENUATE LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION IN PORCINE ANTERIOR UVEAL EXPLANTS, EX VIVO
In non-ocular tissues, hydrogen sulfide (H2S) appears to play a dual role in inflammation, with high concentrations of this gas exhibiting pro-inflammatory actions, while low concentrations are anti-inflammatory. Purpose: Since H2S is present in ocular tissues, the present study aimed to investigate the pharmacologic effects of both fast- and slow-H2S- releasing compounds, as well as polysulfides, on inflammation induced by the bacterial lipopolysaccharide (LPS) in an ex vivo porcine model of anterior uveal inflammation. Methods: Isolated porcine iris-ciliary bodies (ICB) were cut into four equivalent quadrants, maintained in oxygenated Krebs-Henseleit solution, and incubated in separate wells of a 24-well culture plate containing 500 µl of RPMI 1640 supplemented with 1% Penicillin-Streptomycin. Quadrants were randomly assigned to the control and treatment groups, with the latter treated with LPS followed by exposure to H2S-releasing compounds: sodium hydrosulfide (NaHS), GYY4137, and polysulfides, diallyl disulfide (DADS), and diallyl tetrasulfide (DATTS). Results: Varying concentrations of LPS (5 – 200 ng/ml) produced increases in the release of pro-inflammatory mediators (TNF-α, IL-6, and PGE2) and a corresponding decrease in the anti-inflammatory marker, IL-10, in the ICB explants. Both fast- (NaHS, 0.001 - 100 µM) and slow-H2S-releasing compounds (GYY4137, 0.001 - 10 µM) and the polysulfides, DADS (0.001 - 300 µM) and DATTS (0.001 pM - 1 µM), caused a concentration-dependent attenuation of LPS-induced increases in the levels of TNF-α, IL-6, and PGE2. In comparison with the polysulfides, the rank order of potency of H2S-releasing compounds in inhibiting the release of PGE2 from ICB explants was: DATTS >> DADS > GYY4137 > NaHS. DATTS (0.001 pM – 10 nM) reversed the LPS (25 ng/ml)-induced decrease in IL-10 production in the explants. Both indomethacin (10 µM) and flurbiprofen (30 µM) inhibited LPS-induced PGE2 production in the explants. Conclusion: Both fast- and slow-H2S-releasing compounds, as well as polysulfides, were effective in reducing LPS-induced inflammation in porcine anterior uveal explants, ex vivo, indicating a potential anti-inflammatory role for the gas in the mammalian anterior uvea. Furthermore, polysulfides can reverse the decrease the production of an anti-inflammatory cytokine during anterior uveal inflammation.
- 7 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHYDROGEN SULFIDE-RELEASING COMPOUNDS ATTENUATE LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION IN PORCINE ANTERIOR UVEAL EXPLANTS, EX VIVO
In non-ocular tissues, hydrogen sulfide (H2S) appears to play a dual role in inflammation, with high concentrations of this gas exhibiting pro-inflammatory actions, while low concentrations are anti-inflammatory. Purpose: Since H2S is present in ocular tissues, the present study aimed to investigate the pharmacologic effects of both fast- and slow-H2S- releasing compounds, as well as polysulfides, on inflammation induced by the bacterial lipopolysaccharide (LPS) in an ex vivo porcine model of anterior uveal inflammation. Methods: Isolated porcine iris-ciliary bodies (ICB) were cut into four equivalent quadrants, maintained in oxygenated Krebs-Henseleit solution, and incubated in separate wells of a 24-well culture plate containing 500 µl of RPMI 1640 supplemented with 1% Penicillin-Streptomycin. Quadrants were randomly assigned to the control and treatment groups, with the latter treated with LPS followed by exposure to H2S-releasing compounds: sodium hydrosulfide (NaHS), GYY4137, and polysulfides, diallyl disulfide (DADS), and diallyl tetrasulfide (DATTS). Results: Varying concentrations of LPS (5 – 200 ng/ml) produced increases in the release of pro-inflammatory mediators (TNF-α, IL-6, and PGE2) and a corresponding decrease in the anti-inflammatory marker, IL-10, in the ICB explants. Both fast- (NaHS, 0.001 - 100 µM) and slow-H2S-releasing compounds (GYY4137, 0.001 - 10 µM) and the polysulfides, DADS (0.001 - 300 µM) and DATTS (0.001 pM - 1 µM), caused a concentration-dependent attenuation of LPS-induced increases in the levels of TNF-α, IL-6, and PGE2. In comparison with the polysulfides, the rank order of potency of H2S-releasing compounds in inhibiting the release of PGE2 from ICB explants was: DATTS >> DADS > GYY4137 > NaHS. DATTS (0.001 pM – 10 nM) reversed the LPS (25 ng/ml)-induced decrease in IL-10 production in the explants. Both indomethacin (10 µM) and flurbiprofen (30 µM) inhibited LPS-induced PGE2 production in the explants. Conclusion: Both fast- and slow-H2S-releasing compounds, as well as polysulfides, were effective in reducing LPS-induced inflammation in porcine anterior uveal explants, ex vivo, indicating a potential anti-inflammatory role for the gas in the mammalian anterior uvea. Furthermore, polysulfides can reverse the decrease the production of an anti-inflammatory cytokine during anterior uveal inflammation.
- 28 December 2023
- Published by Elsevier in Analytical Biochemistry
- Vol. 687, 115448
Development and application of LC-MS/MS method for the quantification of hydrogen sulfide in the eye
- 28 December 2023
- Published by Elsevier in Analytical Biochemistry
- Vol. 687, 115448
Development and application of LC-MS/MS method for the quantification of hydrogen sulfide in the eye
- 30 July 2022
- Published by Elsevier
- p. 491-507
Ocular side effects of drugs administered systemically for treatment of nonocular diseases
- 30 July 2022
- Published by Elsevier
- p. 491-507
Ocular side effects of drugs administered systemically for treatment of nonocular diseases
- 30 July 2022
- Published by Elsevier
- p. 27-32
Physiology
- 14 January 2022
- Published by Elsevier
- p. 15-38
Current trend in the pharmacotherapy of digestive disorders
- 14 January 2022
- Published by Elsevier
- p. 15-38
Current trend in the pharmacotherapy of digestive disorders